A Study of Apatinib Plus Tegafur Gimeracil Oteracil in Recurrent/Metastatic Head and Neck Cancers

NCT03096184 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Squamous Cell Carcinoma

Interventions

DRUG: Apatinib Mesylate Tablets
DRUG: Tegafur Gimeracil Oteracil Potassium Capsules

Sponsor

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University